Live feed16:10:09·218dINSIDERFilingvia QuantisnowSVP, Chief Development Officer Bala Mohan converted options into 250 shares and sold $762 worth of shares (77 units at $9.90), increasing direct ownership by 6% to 2,922 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.MRSN· Mersana Therapeutics Inc.Health CareOriginal source